References
Hsieh L, Nugent D (2008) Factor XIII deficiency. Haemophilia 14(6):1190–1200. doi:10.1111/j.1365-2516.2008
Naderi M, Dorgalaleh A, Tabibian Sh, Alizadeh Sh, Eshghi P, Solaimani G (2013) Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol 3(4):164–172
Lovejoy AE, Reynolds TC, Visich JE, Butine MD, Young G, Belvedere MA, Blain RC, Pederson SM, Ishak LM, Nugent DJ (2006) Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 108(1):57–62
Nugent D (2012) Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study. Thromb Res 130(Suppl 2):S12–S14
Fadoo Z, Merchant Q, Rehman KA (2013) New developments in the management of congenital Factor XIII deficiency. J Blood Med 28(4):65–73. doi:10.2147/JBM.S32693
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ribizzi, G., Farinini, D., Gentile, R. et al. Factor XIII deficiency and head trauma: management and therapy. Neurol Sci 36, 1933–1934 (2015). https://doi.org/10.1007/s10072-015-2284-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2284-0